These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 2866526

  • 1. Discussion on the metabolism of c-myc mRNA and protein.
    Rabbitts TH, van Straaten P, Rabbitts PH, Watson J.
    Proc R Soc Lond B Biol Sci; 1985 Oct 22; 226(1242):79-82. PubMed ID: 2866526
    [Abstract] [Full Text] [Related]

  • 2. Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability.
    Rabbitts PH, Forster A, Stinson MA, Rabbitts TH.
    EMBO J; 1985 Dec 30; 4(13B):3727-33. PubMed ID: 4092694
    [Abstract] [Full Text] [Related]

  • 3. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE, Lieberman R, Sandlund J, Kiwanuka J, Novikovs L, Kirsch I, Hollis G, Magrath IT.
    Cancer Res; 1989 Jun 15; 49(12):3235-41. PubMed ID: 2497974
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus and Burkitt's lymphoma.
    Magrath I, Jain V, Bhatia K.
    Semin Cancer Biol; 1992 Oct 15; 3(5):285-95. PubMed ID: 1335792
    [Abstract] [Full Text] [Related]

  • 5. Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells.
    Polack A, Eick D, Koch E, Bornkamm GW.
    EMBO J; 1987 Oct 15; 6(10):2959-64. PubMed ID: 3691477
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of a translocated c-myc gene: role of structural alterations in the upstream region.
    Wiman KG, Clarkson B, Hayday AC, Saito H, Tonegawa S, Hayward WS.
    Proc Natl Acad Sci U S A; 1984 Nov 15; 81(21):6798-802. PubMed ID: 6593728
    [Abstract] [Full Text] [Related]

  • 8. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J, Pawlita M, Bullerdiek J, zur Hausen H.
    Cancer Res; 1990 May 15; 50(10):3095-100. PubMed ID: 2159373
    [Abstract] [Full Text] [Related]

  • 9. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA, Luscombe MJ, Clemens MJ.
    Oncogene; 1989 Aug 15; 4(8):1043-6. PubMed ID: 2548145
    [Abstract] [Full Text] [Related]

  • 10. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA, Chang L, Buzby JS, Suen Y, Cairo MS.
    Leukemia; 1996 Dec 15; 10(12):1980-9. PubMed ID: 8946941
    [Abstract] [Full Text] [Related]

  • 11. Regulation of c-myc expression by IFN in Burkitt's lymphoma cells.
    Salehzada T, Blanchard JM, Mechti N, Piechaczyk M, Dani C, Jeanteur P, Lebleu B.
    Prog Clin Biol Res; 1985 Dec 15; 202():211-7. PubMed ID: 3832071
    [No Abstract] [Full Text] [Related]

  • 12. C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma.
    Schlee M, Hölzel M, Bernard S, Mailhammer R, Schuhmacher M, Reschke J, Eick D, Marinkovic D, Wirth T, Rosenwald A, Staudt LM, Eilers M, Baran-Marszak F, Fagard R, Feuillard J, Laux G, Bornkamm GW.
    Int J Cancer; 2007 Apr 01; 120(7):1387-95. PubMed ID: 17211884
    [Abstract] [Full Text] [Related]

  • 13. Translocations among antibody genes in human cancer.
    Leder P.
    IARC Sci Publ; 1985 Apr 01; (60):341-57. PubMed ID: 4065947
    [Abstract] [Full Text] [Related]

  • 14. Breakage on chromosome 2 brings the Ck gene to a region 3' of c-myc in a Burkitt's lymphoma line carrying a (2;8) translocation.
    Malcolm S, Davis M, Rabbitts TH.
    Cytogenet Cell Genet; 1985 Apr 01; 39(3):168-72. PubMed ID: 3930155
    [Abstract] [Full Text] [Related]

  • 15. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D, Polack A, Kofler E, Bornkamm GW.
    Oncogene; 1988 Oct 01; 3(4):397-403. PubMed ID: 3078949
    [Abstract] [Full Text] [Related]

  • 16. Expression of c-myc and c-Ha-ras oncogenes in human lymphoblastoid cells (Namalva).
    Mahmoudi M, Motoo Y, Vela GR, Bollon AP, Osther K.
    Cell Mol Biol; 1989 Oct 01; 35(1):75-80. PubMed ID: 2650877
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.
    Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R, Rabbitts TH.
    EMBO J; 1985 Aug 01; 4(8):2009-15. PubMed ID: 4065102
    [Abstract] [Full Text] [Related]

  • 18. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
    Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B.
    Proc Natl Acad Sci U S A; 2003 Jul 08; 100(14):8164-9. PubMed ID: 12808131
    [Abstract] [Full Text] [Related]

  • 19. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
    Mac SM, Farnham PJ.
    Mol Carcinog; 2000 Feb 08; 27(2):84-96. PubMed ID: 10657901
    [Abstract] [Full Text] [Related]

  • 20. Sequence determinants of c-myc mRNA turn-over: influence of 3' and 5' non-coding regions.
    Bonnieu A, Piechaczyk M, Marty L, Cuny M, Blanchard JM, Fort P, Jeanteur P.
    Oncogene Res; 1988 Sep 08; 3(2):155-66. PubMed ID: 3226724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.